Selective Inhibition of Soluble TNF using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice

MLA

Nancy Nixon-Lee, et al. “Selective Inhibition of Soluble TNF Using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice.” CNS & Neurological Disorders - Drug Targets, vol. 22, Nov. 2023, pp. 1378–90. EBSCOhost, https://doi.org/10.2174/1871527321666220610104908.

APA

Nancy Nixon-Lee, Melissa Damon, Kirsty J. Dixon, Katelyn Larson, & Rajasa Randhi. (2023). Selective Inhibition of Soluble TNF using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice. CNS & Neurological Disorders - Drug Targets, 22, 1378–1390. https://doi.org/10.2174/1871527321666220610104908

Chicago

Nancy Nixon-Lee, Melissa Damon, Kirsty J. Dixon, Katelyn Larson, and Rajasa Randhi. 2023. “Selective Inhibition of Soluble TNF Using XPro1595 Improves Hippocampal Pathology to Promote Improved Neurological Recovery Following Traumatic Brain Injury in Mice.” CNS & Neurological Disorders - Drug Targets 22 (November): 1378–90. doi:10.2174/1871527321666220610104908.